We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

A robot arm holding a gear touching a human hand also holding a gear
Industry Insight

The Role of Automation in Industrializing Cell Therapy Manufacturing

Technology Networks spoke to Dr. Dan Strange, CTO at Cellular Origins, to discuss how integrating proven tools and technologies, such as automation, helps cell therapy companies scale up production.
A lab scientist holding a glass vial containing a liquid with a DNA strand
Industry Insight

Cutting Biotherapeutic Development Timelines With Advanced Microfluidics

In this interview, Dr. Graeme Daniels, Sphere Fluidics, shares how advanced microfluidics are set to revolutionize biotherapeutic workflows and discusses the technology's future potential in broader applications, including cell and gene therapy.
Lab scientists reviewing medical images
Industry Insight

Biotech Start-Ups Share How They Are Addressing Key Limitations in Disease Models

Technology Networks asked a selection of start-up companies at ELRIG Drug Discovery how their technology addresses key limitations in traditional disease models.
RNA Polymerase II transcribing DNA into RNA.
Industry Insight

Getting New Drug Modalities to Market: How Can Your Data Strategy Help?

This article explores the revolution in new drug modalities and the challenges around effective data strategies to support AI efforts.
A glowing award icon.
Industry Insight

Innovation Award Winner Announced at ELRIG Drug Discovery 2024

Technology Networks had the pleasure of speaking with the ELRIG Innovation Award Winner Constructive Bio’s CEO, Dr. Ola Wlodek, to discuss its award-winning innovations and learn more about its mission.
An image of James Hallam, vice president of the Research, Development and Advanced Testing Business Segment at Waters Corporation.
Industry Insight

Next-Generation Solutions for Discovery Omics

Learn from James Hallam, vice president of the Research, Development and Advanced Testing Business segment at Waters Corporation, about how technological advancements in mass spectrometry are powering new discoveries in omics research.
A lab scientist holding test tubes containing blood samples for bioanlysis.
Industry Insight

Overcoming Challenges in Bioanalysis With Artificial Intelligence

In bioanalysis, AI could alleviate preclinical and clinical bioanalytical data processing and analysis. Here, Mary Belfast from Teva Branded Pharmaceuticals, discusses some of the latest guidelines on AI implementation and validation in bioanalysis.
A veteran with PTSD sits on a sofa.
Industry Insight

After MDMA’s FDA Approval Setback, Science Must Lead the Way

Dr. Sergio Pérez Rosal explains why, in his opinion, “hope is not lost” and the therapeutic potential of psychedelics for the treatment of psychiatric disorders could still be unlocked. But what happens next must be firmly rooted in science.
Two reagent bottles standing side-by-side with labels commemorating 50 years of DoCoLab.
Industry Insight

Understanding Doping Control in Sports: An Interview With Professor Peter Van Eenoo

We sat down with Professor Peter Van Eenoo, director of the Doping Control Laboratory (DoCoLab), part of the University of Ghent, Belgium, to discuss the intricacies of anti-doping testing and the challenges faced in catching sporting cheats.
A female researcher seen from the side looks across at a tablet surrounded by data symbols.
Industry Insight

Harnessing AI and Automation for the Future of Drug Discovery

In this interview, Tola Olorunnisola, senior vice president and general manager at Avantor, delves into how AI and automation could put the Lab of the Future within our grasp, enabling scientific breakthroughs and revolutionizing the drug development process.
Advertisement